FUNCTIONAL EXPRESSION OF THE P-GLYCOPROTEIN MDR IN PRIMARY CULTURES OF BOVINE CEREBRAL CAPILLARY ENDOTHELIAL-CELLS

被引:15
作者
LECHARDEUR, D [1 ]
SCHERMAN, D [1 ]
机构
[1] RHONE POULENC RORER,CTR RECH VITRY ALFORTVILLE,CNRS,UMR 133,F-94403 VITRY,FRANCE
关键词
BLOOD-BRAIN BARRIER; ENDOTHELIAL CELLS; MULTIDRUG RESISTANCE; BETA-GLYCOPROTEIN;
D O I
10.1007/BF00757626
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The P-glycoprotein mdr is expressed not only in tumoral cells, but also in nontransformed cells, including the specialized endothelial cells of brain capillaries which build up the blood-brain barrier. Since all previously identified blood-brain barrier markers are rapidly lost when cerebral capillary endothelial cells are maintained in primary culture, we have investigated whether P-glycoprotein (P-gp) would follow the same rule, in order to address the influence of the cerebral environment on the specific P-gp expression in the brain endothelium. As compared to freshly isolated purified cerebral capillaries, P-glycoprotein was detected by immunochemistry at a high level in 5-7 day primary cultures. In our culture conditions, P-glycoprotein was immunodetected at a lower molecular weight than that found in freshly isolated capillaries. Enzymatic deglycosylation led to the same 130 kDa protein for both fresh and cultured samples, suggesting that P-gp posttranslational modifications were altered in primary cultures. However, studies on the uptake and efflux of the P-gp substrate [H-3]vinblastine, and on the effect of various mdr reversing agents on the uptake and efflux, clearly indicated that the efflux pump function of the P-glycoprotein was maintained in primary cultures of bovine cerebral capillary endothelial cells. P-Glycoprotein may thus represent the first blood-brain barrier marker which is maintained in cerebral endothelial cells cultured in the absence of factors originating from the brain parenchyma.
引用
收藏
页码:283 / 293
页数:11
相关论文
共 37 条
[21]   P-GLYCOPROTEIN CONTENT AND MEDIATION OF VINCRISTINE EFFLUX - CORRELATION WITH THE LEVEL OF DIFFERENTIATION IN LUMINAL EPITHELIUM OF MOUSE SMALL-INTESTINE [J].
MEYERS, MB ;
SCOTTO, KW ;
SIROTNAK, FM .
CANCER COMMUNICATIONS, 1991, 3 (05) :159-165
[22]   A ROUTINE PROCEDURE FOR ESTIMATING SERUM GAMMA-GLUTAMYLTRANSPEPTIDASE ACTIVITY [J].
NAFTALIN, L ;
SEXTON, M ;
WHITAKER, JF ;
TRACEY, D .
CLINICA CHIMICA ACTA, 1969, 26 (02) :293-&
[23]  
PARDRIDGE WM, 1990, PEPTIDE DRUG DELIVER, P280
[24]   IMMUNOHISTOCHEMICAL DETECTION OF THE MULTIDRUG TRANSPORT PROTEIN P170 IN HUMAN NORMAL-TISSUES AND MALIGNANT-LYMPHOMAS [J].
PILERI, SA ;
SABATTINI, E ;
FALINI, B ;
TAZZARI, PL ;
GHERLINZONI, F ;
MICHIELI, MG ;
DAMIANI, D ;
ZUCCHINI, L ;
GOBBIS, M ;
TSURUO, T ;
BACCARANI, M .
HISTOPATHOLOGY, 1991, 19 (02) :131-140
[25]   A CELL-CULTURE MODEL OF THE BLOOD-BRAIN-BARRIER [J].
RUBIN, LL ;
HALL, DE ;
PORTER, S ;
BARBU, K ;
CANNON, C ;
HORNER, HC ;
JANATPOUR, M ;
LIAW, CW ;
MANNING, K ;
MORALES, J ;
TANNER, LI ;
TOMASELLI, KJ ;
BARD, F .
JOURNAL OF CELL BIOLOGY, 1991, 115 (06) :1725-1735
[26]  
SAFA AR, 1990, J BIOL CHEM, V265, P16509
[27]   DISRUPTION OF THE MOUSE MDR1A P-GLYCOPROTEIN GENE LEADS TO A DEFICIENCY IN THE BLOOD-BRAIN-BARRIER AND TO INCREASED SENSITIVITY TO DRUGS [J].
SCHINKEL, AH ;
SMIT, JJM ;
VANTELLINGEN, O ;
BEIJNEN, JH ;
WAGENAAR, E ;
VANDEEMTER, L ;
MOL, CAAM ;
VANDERVALK, MA ;
ROBANUSMAANDAG, EC ;
TERIELE, HPJ ;
BERNS, AJM ;
BORST, P .
CELL, 1994, 77 (04) :491-502
[28]  
SHIMABUKU AM, 1992, J BIOL CHEM, V267, P4308
[29]   SPECIALIZED LOCALIZATION OF P-GLYCOPROTEIN RECOGNIZED BY MRK 16 MONOCLONAL-ANTIBODY IN ENDOTHELIAL-CELLS OF THE BRAIN AND THE SPINAL-CORD [J].
SUGAWARA, I ;
HAMADA, H ;
TSURUO, T ;
MORI, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1990, 81 (08) :727-730
[30]  
TATSUTA T, 1992, J BIOL CHEM, V82, P20383